Admission Date:  [**2125-5-14**]     Discharge Date:  [**2125-5-19**]  Date of Birth:   [**2125-5-14**]     Sex:  F  Service:  Neonatology  HISTORY OF PRESENT ILLNESS:  Baby girl [**Known lastname 7749**] is a 33-5/7 weeks gestational age female (twin II) admitted for management of prematurity.
PRENATAL SCREENS:  Blood type O positive, antibody negative, Rubella immune, rapid plasma reagin nonreactive, hepatitis B surface antigen negative, and group B strep status unknown.
PREGNANCY HISTORY:  Estimated date of delivery was [**2125-6-27**] for estimated gestational age of 33-5/7 weeks.
Course of betamethasone was completed at that time.
A magnesium sulfate tocolysis was administered through 32 weeks and was then switched to terbutaline.
Rupture of membranes for this twin at delivery yielded clear amniotic fluid.
Antepartum antibiotic prophylaxis administered from 15 hours prior to delivery.
Oral and nasal bulb suctioned dry, subsequently pink and in no distress on room air.
She was transferred to the Neonatal Intensive Care Unit uneventfully for further management of prematurity.
FLUIDS/ELECTROLYTES/NUTRITION:  Intravenous fluids of D-10-W were initiated upon admission to the Newborn Intensive Care Unit of D-10-W at 80 cc/kg per day.
Enteral feeds were initiated on the day of life one at 40 cc/kg of PE-20 or breast milk.
Bili on [**2125-5-18**] was 9.2/0.3 - phototherapy was discontinued with plans for a follow up bilirubin tomorrow.
She has not received any blood products throughout her hospitalization.
feeds of premature Enfamil 20-calorie at 140 cc/kg per day.
Follow-up bilirubin off phototherapy should be checked tomorrow morning.
IMMUNIZATIONS:  [**Last Name (un) 17976**] has not received any immunizations at the time of transfer.
